Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Participant Experiences with EMPOWER: Benefits, Barriers, and Best Practices for an Online Peer Mentorship and Leadership Program for Women in Academic Medicine.

Women's health reports (New Rochelle, N.Y.)·2026
Same author

Defining Expanded Episode-Based Surgical Quality Measurement.

JAMA network open·2026
Same author

Identifying gaps in surgical quality measurement using an episodes of care framework.

Surgery·2026
Same author

Medicare Advantage and Quality Measurement-A System at Risk.

JAMA·2026
Same author

Developing a Weight Management and Metabolic Health Program to support patient-centred, effective, and efficient treatment for veterans with overweight or obesity: protocol for a quality improvement programme.

Primary health care research & development·2026
Same author

Right-Sizing Testing Before Elective Surgery for Patients With Low Risk.

JAMA network open·2025

Related Experiment Videos

Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled

Michele Heisler1, Timothy P Hofer, Mandi L Klamerus

  • 1Veterans Affairs Center for Clinical Management Research, VA Ann Arbor Healthcare System 2215 Fuller Road, Ann Arbor, MI 48105, USA. mheisler@umich.edu

Trials
|October 14, 2010
PubMed
Summary

A clinical pharmacist intervention improved blood pressure (BP) control in diabetes patients by proactively identifying those with poor BP control and addressing medication adherence and intensification. This team-based approach is key for managing high-risk patients effectively.

Related Experiment Videos

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Health Services Research

Background:

  • Many patients with diabetes exhibit suboptimal blood pressure (BP) control, often due to poor medication adherence and infrequent treatment intensification.
  • Effective BP management necessitates a collaborative approach between healthcare providers and patients for medication adherence and regimen adjustments.

Purpose of the Study:

  • To evaluate the effectiveness of a clinical pharmacist-led intervention program aimed at improving BP control in patients with diabetes.
  • To assess the impact of proactive patient identification, adherence counseling, and medication intensification on BP management.

Main Methods:

  • A cluster-randomized controlled effectiveness study involving primary care teams across five facilities.
  • Intervention group: Clinical pharmacist utilizing motivational interviewing and authorized to adjust BP medications.
  • Control group: Usual care. Data collected over 14 months, with primary outcome being change in systolic blood pressure (SBP).

Main Results:

  • The intervention integrated proactive identification, adherence counseling, and medication intensification.
  • This integrated approach is crucial for achieving optimal BP control in high-risk patient populations.
  • Team-level testing reflects real-world clinical implementation and integration into existing care.

Conclusions:

  • The study highlights the essential role of a multi-component intervention for improving BP control in patients with diabetes.
  • Team-based implementation of pharmacist-led interventions can enhance medication management and patient outcomes.
  • This model demonstrates effective integration within a clinical setting for high-risk patients.